ReviewExpert opinion on investigational drugs2020

GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH).

Naim Alkhouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.